Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2 clinical trials
A Phase 1 Study to Assess the Immunogenicity of QL0605 Compared to US Neulasta in Healthy Subjects

Pharmaceutical Co., Ltd. proposed biosimilar QL0605 compared to innovator product, US-Neulasta) in healthy, adult, human subjects.

  • 0 views
  • 27 Jan, 2021
  • 2 locations
Vaccination With Flt3L Radiation and Poly-ICLC

blood cell growth factors (Neupogen or Neulasta) or red blood cell growth factors (EPO or Epogen) that you may have received to help protect your blood cells previously. Flt3L causes your body to make

tumor cells
chronic lymphocytic leukemia
growth factor
poly iclc
cancer
  • 30 views
  • 26 Oct, 2021
  • 1 location